Bioinformatics a niche sector The challenge for Indian bioinformatics
companies is to create proprietary products that will generate
Bioinformatics a niche sector
The challenge for Indian bioinformatics companies is to create proprietary
products that will generate high-margin revenues.
Biotech researchers need computational horsepower as well as
superior algorithms to do prediction and hypothesize information. Biotech's
sub-industry, bioinformatics which caters to this, could exceed $19 billion in
revenues in 2006 globally. Roughly 10 percent of the biotech industry spending
is for informatics hardware, systems, software and services. Considering the
global biotech industry growth at roughly 25 percent, a substantial amount would
be spent on bioinformatics by all biotech companies. Hence, bioinformatics would
be a niche sector in the biotech industry.
Outsourcing of bioinformatics has benefited Indian
bioinformatics companies. Most of the work has happened in core sectors of
bioinformatics services such as data analysis, gene annotation, database
creation and algorithm and software development. Though there has been
considerable success of the biotech markets globally, India still has a small
opportunity in the bioinformatics space. There is a huge potential for this to
grow. With revenues of around $20 million during the year ending 2005, the
Indian companies are marching ahead for a larger share in the marketplace. The
expectation for the year 2006 would be around $50 to 60 million overall
According to other published reports, there are about 45 companies in the
bionformatics space, based mostly in Bangalore, Chennai and Hyderabad with a few
in Delhi and Pune. Multinationals also have shown their presence in India
recently, and most of them are established players in the biotech sector and
some in bioinformatics too. It would be difficult for new entrants in this space
in India as the sector requires managing trained resources effectively and not
seeking benefits in costs and pricing. However, the challenge for Indian
bioinformatics companies is to create proprietary products that will generate
high-margin revenues and focus less on low-margin service work attracting cost
conscious foreign companies.
Page(s) 1 |